The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124776085 12477608 5 F 20160609 20160803 20160617 20160809 EXP MX-BAYER-2016-115983 BAYER 62.00 YR A F Y 48.00000 KG 20160809 CN MX MX

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124776085 12477608 1 PS NEXAVAR SORAFENIB 1 400 MG, BID 21923 400 MG FILM-COATED TABLET BID
124776085 12477608 2 C LOSARTAN. LOSARTAN 1 2 DF, QD 0 2 DF QD
124776085 12477608 3 C METOPROLOL. METOPROLOL 1 1 DF, BID 0 1 DF BID
124776085 12477608 4 C INSULIN INSULIN NOS 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124776085 12477608 1 Hepatocellular carcinoma
124776085 12477608 2 Hypertension

Outcome of event

Event ID CASEID OUTC COD
124776085 12477608 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124776085 12477608 Alopecia
124776085 12477608 Asthenia
124776085 12477608 Diarrhoea
124776085 12477608 Discomfort
124776085 12477608 Fatigue
124776085 12477608 Hepatic pain
124776085 12477608 Hyperglycaemia
124776085 12477608 Hypertension
124776085 12477608 Hypoaesthesia
124776085 12477608 Hypoglycaemia
124776085 12477608 Injection site haemorrhage
124776085 12477608 Muscular weakness
124776085 12477608 Myalgia
124776085 12477608 Oedema peripheral
124776085 12477608 Skin induration
124776085 12477608 Somnolence
124776085 12477608 Systemic lupus erythematosus
124776085 12477608 Thirst
124776085 12477608 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124776085 12477608 1 20160328 0